張莉,研究員,博士生導(dǎo)師。本科畢業(yè)于中山大學(xué)公共衛(wèi)生學(xué)院預(yù)防醫(yī)學(xué)專(zhuān)業(yè),博士畢業(yè)于北京協(xié)和醫(yī)學(xué)院流行病與衛(wèi)生統(tǒng)計(jì)專(zhuān)業(yè)。曾獲WHO/IARC博士后獎(jiǎng)學(xué)金、2020年國(guó)際乳頭瘤病毒大會(huì)會(huì)議獎(jiǎng)學(xué)金、2018年亞洲及太平洋癌癥預(yù)防組織大會(huì)最佳口頭報(bào)告獎(jiǎng)、2018年中國(guó)腫瘤學(xué)大會(huì)中青年優(yōu)秀論文三等獎(jiǎng)、2017國(guó)際乳頭瘤病毒大會(huì)會(huì)議獎(jiǎng)學(xué)金。
     院校引進(jìn)人才,2023年加入院校。曾于2019年11月-2022年12月在世界衛(wèi)生組織/國(guó)際癌癥研究署(WHO/IARC)從事博士后研究員工作。
依托國(guó)內(nèi)以人群為基礎(chǔ)的腫瘤篩查長(zhǎng)期隨訪隊(duì)列和國(guó)際腫瘤篩查實(shí)施評(píng)估平臺(tái),在常見(jiàn)惡性腫瘤的篩查方案優(yōu)化、組織實(shí)施評(píng)估、國(guó)際專(zhuān)家共識(shí)等領(lǐng)域開(kāi)展了一系列研究,研究成果被國(guó)際權(quán)威手冊(cè)/指南引用,并多次獲得國(guó)際會(huì)議的會(huì)議獎(jiǎng)學(xué)金資助。以第一作者身份在 Nature Medicine,EClinicalMedicine,BMC Medicine 等雜志發(fā)表論文十余篇,主持醫(yī)科院創(chuàng)新工程、世界衛(wèi)生組織/國(guó)際癌癥研究署(WHO/IARC)博士后歸國(guó)基金、國(guó)家自然科學(xué)基金、科技部海外博士后引才項(xiàng)目等研究。
1. Zhong P, Zhang L*, Zhao F*. Modeling cervical cancer elimination: a pathway to inform policy decisions. Cancer Biol Med. 2025 Oct 6;22(9):1002–9.
2. Han J#, Zhang L#, Chen Y#, Zhang Y, Wang L, Cai R, Li M, Dai Y, Dang L, Chen H*, Zhu L*. Global HPV vaccination programs and coverage rates: a systematic review. EClinicalMedicine. 2025 Jun 9;84:103290.
3. Li Zhang#, Isabel Mosquera, Eric Lucas, Mary Luz Rol, Andre L. Carvalho, Partha Basu*, CanScreen5 collaborators. Organisation and implementation of breast, cervical and colorectal cancer screening programmes from 84 countries: the CanScreen5 global repository, Nature Medicine, 2023;29(5):1135-1145.
4. Li Zhang#, Catherine Sauvaget, Isabel Mosquera, Partha Basu*. Efficacy, acceptability and safety of ablative vs excisional procedure in the treatment of histologically confirmed CIN2-3: a systematic review. BJOG. 2023;130(2):153-61.
5. Li Zhang#, André L Carvalho, Isabel Mosquera, Tianmeng Wen, Eric Lucas, Catherine Sauvaget, Richard Muwonge, Marc Arbyn, Elisabete Weiderpass, Partha Basu*. An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Med. 2022,23;20(1):101. (R)
6. Li Zhang#, Xuelian Zhao, Shangying Hu, Shimin Chen, Shuang Zhao, Li Dong, André L Carvalho, Richard Muwonge, Fanghui Zhao*, Partha Basu. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study. Int J Cancer.2022;151(6):878-87.
7. Mengmeng Li#*, Li Zhang#, Hadrien Charvat*, Matthew E. Callister, Peter Sasieni, Evangelia Christodoulou, Rudolf Kaaks, Mattias Johansson, Andre L. Carvalho, Salvatore Vaccarella, Hilary A. Robbins*. The influence of post-screening follow-up time and other factors on estimates of overdiagnosis from lung cancer screening trials. Int J Cancer. 2022;151(9):1491-501.